The budget is silent on ways and policies to boost domestic R&D in MedTech: J Mitra & Co

February 03, 2022 | Thursday | Views

Jatin Mahajan, MD, J Mitra & Co and Jt Coordinator (IVD) @ AiMeD

Image credit: linkedin

Image credit: linkedin

"We are dismayed by the Union Budget 2022 completely overlooking the fair expectations of the MedTech industry. There has been a lot of focus on future-speak – with elaborate mentions of digital and infrastructure, but the existing concerns of MedTech industry have been completely neglected. The budget is silent on ways and policies to boost domestic R&D in MedTech / healthcare segment."

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy